at the next conference
good! at least we can read the lines of why it failed...
I guess there is no broker following vical now. only Johnson is there... Vical has no way to raise money by diluting stocks :)
why would knowing why/how allovectin failed help this stock in anyway...seems irrelvant to me at this point.